The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
This takes place after the transduction of the messenger RNA (mRNA) from NRF-2, binding a homodimer of KEAP1, and afterward, binding with a full dimer, resulting in the degradation of NRF-2 by the previously mentioned Neh [21]
Pala L, Ciani S, Bardini G, Pezzatini A, Sposato L, Cremasco F, Ognibene A, Rotella
Dziki temu do uszkodzonych tkanek dostarczana jest wiksza ilo tlenu i skadnikw odywczych, co przyspiesza procesy naprawcze
, , B-12 , ,